Insider transactions Exelixis, Inc.

Stocks

EXEL

US30161Q1040

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:04:06 14/07/2026 am IST			5-day change	1st Jan Change
55.82 ^USD	-1.21%		+0.52%	+27.36%

03:04pm	Analyst recommendations: Biogen, Deckers Outdoor, Fortinet, Marathon Petroleum, UnitedHealth…
07/07	RBC Capital Adjusts Exelixis Price Target to $46 From $43, Maintains Sector Perform Rating	MT

Insider Transaction History

Latest insider transactions for Exelixis, Inc.

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
01/06	Sue Gail Eckhardt	Sell	Director	-9,812	50.14	-	0.0039%
01/06	Jack Wyszomierski	Sell	Director	-3,925	50.55	-	0.0016%
27/05	Mary Beckerle	Free	Director	8,367	-	-	0.0033%
27/05	Maria Freire	Free	Director	8,367	-	-	0.0033%
27/05	Sue Gail Eckhardt	Free	Director	8,367	-	-	0.0033%
27/05	Jack Wyszomierski	Free	Director	8,367	-	-	0.0033%
27/05	Stelios Papadopoulos	Free	Founder	8,367	-	-	0.0033%
27/05	Julie Smith	Free	Director	8,367	-	-	0.0033%
27/05	David Johnson	Free	Director	19,133	50.48	10L	0.0075%
27/05	George Poste	Free	Director	8,367	-	-	0.0033%
27/05	Robert Oliver	Free	Director	8,367	-	-	0.0033%
27/05	Tomas Jan Heyman	Free	Director	8,367	-	-	0.0033%
26/05	Dana Aftab	Sell	Chief Technology Officer	-43,451	50.35	-	0.0171%
20/05	Patrick Haley	Sell	Executive/Senior Manager	-32,110	49.81	-	0.0126%
18/05	Michael Morrissey	Don	Chief Executive Officer	-2,48,094	-	-	0.0977%
18/05	Christopher Senner	Sell	Chief Financial Officer	-34,901	50.00	-	0.0137%
18/05	Brenda Hefti	Sell	General Counsel	-6,625	50.21	-	0.0026%
15/05	Dana Aftab	Tax	Chief Technology Officer	-30,578	51.10	-	0.0120%
15/05	Patrick Haley	Tax	Executive/Senior Manager	-33,265	51.10	-	0.0131%
07/05	Mary Beckerle	Fiscal year	Director	15,424	40.05	5L	0.0061%
07/05	George Poste	Sell	Director	-60,000	45.71	-	0.0236%
07/05	Maria Freire	Fiscal year	Director	61,902	32.88	13.57L	0.0244%
06/05	Michael Morrissey	Don	Chief Executive Officer	-1,09,676	-	-	0.0432%
26/02	Patrick Haley	Free	Executive/Senior Manager	40,459	-	-	0.0151%
26/02	Dana Aftab	Free	Chief Technology Officer	52,018	-	-	0.0194%
26/02	Brenda Hefti	Free	General Counsel	23,119	-	-	0.0086%
26/02	Christopher Senner	Free	Chief Financial Officer	52,018	-	-	0.0194%
24/02	Michael Morrissey	Don	Chief Executive Officer	2,60,715	-	-	0.0972%
24/02	Dana Aftab	Sell	Chief Technology Officer	47,918	44.50	21.32L	0.0179%
19/02	Dana Aftab	Sell	Chief Technology Officer	29,873	44.35	13.25L	0.0111%
18/02	Jack Wyszomierski	Fiscal year	Director	1,40,842	39.85	47.9L	0.0525%
17/02	Julie Smith	Fiscal year	Director	3,19,617	31.67	67.48L	0.1192%
15/02	Patrick Haley	Tax	Executive/Senior Manager	99,297	43.64	43.34L	0.0370%
15/02	Dana Aftab	Tax	Chief Technology Officer	39,205	43.92	17.22L	0.0146%
15/02	Brenda Hefti	Tax	General Counsel	24,099	43.99	10.6L	0.0090%
13/02	Michael Morrissey	Fiscal year	Chief Executive Officer	22,31,056	18.47	3.21Cr	0.8321%
13/02	Robert Oliver	Fiscal year	Director	48,426	38.15	15.01L	0.0181%
13/02	Christopher Senner	Sell	Chief Financial Officer	1,00,765	43.53	43.86L	0.0376%
13/02	Sue Gail Eckhardt	Sell	Director	3,856	43.79	2L	0.0014%
15/01	Dana Aftab	Free	Chief Technology Officer	1,46,832	8.40	12.33L	0.0548%
15/01	Christopher Senner	Free	Chief Financial Officer	1,89,933	9.63	18.3L	0.0708%
15/01	Patrick Haley	Free	Executive/Senior Manager	1,71,840	8.51	14.62L	0.0641%
15/01	Michael Morrissey	Free	Chief Executive Officer	6,87,597	9.18	63.11L	0.2565%
03/12	Brenda Hefti	Free	General Counsel	30,170	-	-	0.0113%
25/11	David Johnson	Other	Director	0	-	-	0%
25/11	Caligan Partners LP	Buy	Company	27,532	43.12	11.87L	0.0102%
21/11	Dana Aftab	Don	Chief Technology Officer	24,000	-	-	0.0089%
20/11	Patrick Haley	Sell	Executive/Senior Manager	72,230	42.18	30.47L	0.0268%
17/11	Robert Oliver	Don	Director	1,044	-	-	0.0004%
12/11	Stelios Papadopoulos	Sell	Founder	1,00,000	43.55	43.55L	0.0371%